214 related articles for article (PubMed ID: 23521868)
1. Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers.
Smith KA; Gray NJ; Cheek E; Saleh F; Lavender J; Frew AJ; Kern F; Tarzi MD
BMC Immunol; 2013 Mar; 14():14. PubMed ID: 23521868
[TBL] [Abstract][Full Text] [Related]
2. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
3. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
[TBL] [Abstract][Full Text] [Related]
4. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
[TBL] [Abstract][Full Text] [Related]
5. Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy.
Guida G; Boita M; Scirelli T; Bommarito L; Heffler E; Badiu I; Bellone G; Mietta S; Mistrello G; Rolla G
Allergy Asthma Proc; 2012; 33(5):411-5. PubMed ID: 22762741
[TBL] [Abstract][Full Text] [Related]
6. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children.
Jenmalm MC; Van Snick J; Cormont F; Salman B
Clin Exp Allergy; 2001 Oct; 31(10):1528-35. PubMed ID: 11678852
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.
Movérare R; Elfman L; Björnsson E; Stålenheim G
Immunol Lett; 2000 Jul; 73(1):51-6. PubMed ID: 10963811
[TBL] [Abstract][Full Text] [Related]
8. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
9. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
[TBL] [Abstract][Full Text] [Related]
10. Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen.
Assing K; Nielsen CH; Poulsen LK
Clin Exp Allergy; 2006 Mar; 36(3):283-92. PubMed ID: 16499638
[TBL] [Abstract][Full Text] [Related]
11. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
[TBL] [Abstract][Full Text] [Related]
12. Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells.
Neunkirchner A; Leb-Reichl VM; Schmetterer KG; Mutschlechner S; Kueng HJ; Haiderer D; Schuch K; Wallner M; Jahn-Schmid B; Bohle B; Pickl WF
J Immunol; 2011 Oct; 187(8):4077-87. PubMed ID: 21908735
[TBL] [Abstract][Full Text] [Related]
13. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
14. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
Nieminen K; Laaksonen K; Savolainen J
Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
[TBL] [Abstract][Full Text] [Related]
15. Study of the Th1/Th2 balance, including IL-10 production, in cultures of peripheral blood mononuclear cells from birch-pollen-allergic patients.
Movérare R; Elfman L; Stålenheim G; Björnsson E
Allergy; 2000 Feb; 55(2):171-5. PubMed ID: 10726732
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
Casas R; Lindau C; Zetterström O; Duchén K
Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
[TBL] [Abstract][Full Text] [Related]
17. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12.
Jahn-Schmid B; Siemann U; Zenker A; Bohle B; Messner P; Unger FM; Sleytr UB; Scheiner O; Kraft D; Ebner C
Int Immunol; 1997 Dec; 9(12):1867-74. PubMed ID: 9466314
[TBL] [Abstract][Full Text] [Related]
18. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production in peripheral blood cells during and outside the pollen season in birch-allergic patients and non-allergic controls.
Wosinska-Becler K; Plewako H; Håkansson L; Rak S
Clin Exp Allergy; 2004 Jan; 34(1):123-30. PubMed ID: 14720272
[TBL] [Abstract][Full Text] [Related]
20. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.
Klimek L; Dormann D; Jarman ER; Cromwell O; Riechelmann H; Reske-Kunz AB
Clin Exp Allergy; 1999 Oct; 29(10):1326-35. PubMed ID: 10520053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
